These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9322906)

  • 21. FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management.
    Pelosi E; Penna D; Deandreis D; Chiappella A; Skanjeti A; Vitolo U; Bisi G
    Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):9-16. PubMed ID: 18235420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow involvement by non-Hodgkin's lymphom.
    Lee WI; Lee JH; Kim IS; Lee KN; Kim SH
    J Korean Med Sci; 1994 Oct; 9(5):402-8. PubMed ID: 7702789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-dimensional reconstruction of non-Hodgkin's lymphoma in bone marrow trephines.
    Salisbury JR; Deverell MH; Seaton JM; Cookson MJ
    J Pathol; 1997 Apr; 181(4):451-4. PubMed ID: 9196445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Value of "non-specific" lymphoid infiltrates in bone marrow in high grade malignant peripheral non-Hodgkin's lymphomas].
    Budde R; Schaefer HE
    Verh Dtsch Ges Pathol; 1992; 76():136-9. PubMed ID: 1283244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pattern of bone marrow infiltration in non-Hodgkin's lymphomas.
    Hassan K; Ikram N; Bukhari KP; Shah SH
    J Pak Med Assoc; 1995 Jul; 45(7):173-6. PubMed ID: 8523638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Bone marrow biopsy in non-Hodgkin's lymphoma: experience with 259 samples].
    Hernández Nieto L; Hernández García MT; González Brito G; Brito Barroso ML; Marsa Vila L; Chavez MI
    Sangre (Barc); 1989 Aug; 34(4):271-7. PubMed ID: 2772780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute promyelocytic leukemia following treatment of non-Hodgkin's lymphoma.
    Raiker A; Green W; Shabaik A; Perlin E
    Cancer; 1989 Apr; 63(7):1402-6. PubMed ID: 2646008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough?
    O'Neill BP; Dinapoli RP; Kurtin PJ; Habermann TM
    J Neurooncol; 1995; 25(1):67-71. PubMed ID: 8523091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Incidence of lymphoma cells in the bone marrow and peripheral blood in patients with non-Hodgkin's type lymphoma].
    Rajić M; Vidaković B; Bojić P
    Srp Arh Celok Lek; 1989; 117(1-2):27-37. PubMed ID: 2799547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Megakaryocytes emperipolesis in bone marrow of the patients with non-Hodgkin's lymphoma.
    Dziecioł J; Lemancewicz D; Kłoczko J; Bogusłowicz W; Lebelt A
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():142-3. PubMed ID: 11820577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary bone marrow B-cell non-Hodgkin's lymphoma successfully treated with R-CHOP.
    Qian L; Zhang Z; Shen J; Liu Y
    West Indian Med J; 2013 Jan; 62(1):89-91. PubMed ID: 24171336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
    Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
    Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience.
    Bennett JM; Cain KC; Glick JH; Johnson GJ; Ezdinli E; O'Connell MJ
    J Clin Oncol; 1986 Oct; 4(10):1462-9. PubMed ID: 3531421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatal bone marrow necrosis following fludarabine administration in a patient with indolent lymphoma.
    Aboulafia DM; Demirer T
    Leuk Lymphoma; 1995 Sep; 19(1-2):181-4. PubMed ID: 8574166
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Case of Synchronous Bone Marrow Chronic Myelomonocytic Leukemia (CMML) and Nodal Marginal Zone Lymphoma (NMZL).
    Soriano PK; Stone T; Baqai J; Sana S
    Am J Case Rep; 2018 Sep; 19():1135-1139. PubMed ID: 30254190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence and risk factors of bone marrow involvement by non-Hodgkin lymphoma.
    Kittivorapart J; Chinthammitr Y
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S239-45. PubMed ID: 21721453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is bone marrow biopsy obligatory in all patients with non-Hodgkin's lymphoma?
    Bairey O; Shpilberg O
    Acta Haematol; 2007; 118(1):61-4. PubMed ID: 17505131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased expression of CXCR4 chemokine receptor in bone marrow after chemotherapy in patients with non-Hodgkin lymphomas is a good prognostic factor.
    Mazur G; Butrym A; Kryczek I; Dlubek D; Jaskula E; Lange A; Kuliczkowski K; Jelen M
    PLoS One; 2014; 9(5):e98194. PubMed ID: 24859274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and prognostic analysis of 125 cases of non-Hodgkin's lymphoma.
    Liu L; Zhang M; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):547-50. PubMed ID: 18549626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary non-Hodgkin's lymphoma of the thyroid with bone marrow infiltration at presentation.
    el-Sharkawi AM; al-Ismael S; Waters JS
    Clin Oncol (R Coll Radiol); 1995; 7(5):339. PubMed ID: 8580067
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.